Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: To screen or not to screen: an interactive framework for comparing costs of mass malaria treatment interventions

Fig. 5

Urban versus rural comparison of value added from screen then treat in Burkina Faso. Comparison of regional value added (per individual) from diagnostic screening (MDA costs minus MSAT costs) between urban (left plots) and rural (right plots) communities. Positive values (blue) favor MSAT, negative values (red) favor MDA, and 95% interval ranges that contain both positive and negative values indicate no significant difference (gray). Cost of diagnostic test (RDT) and treatment were set at $0.60 and $2.55, respectively. a Added value estimates ignoring any potential costs associated with false negative results. b Value added estimates when cost associated with false negative results is set to the cost of receiving delayed treatment. c Value added estimates when cost associated with false negative results includes the cost of receiving delayed treatment and 1 day of lost wage (based on minimum wage [39]). In all of these scenarios, we assume no cost associated with false positive outcomes

Back to article page
\